Skip to main content
. 2020 Dec 23;320(5):L892–L902. doi: 10.1152/ajplung.00090.2020

Table 5.

Odds of death in 97 septic adults according to neutrophil expression of OLFM4 ≥ 37.6% compared with OLFM4 < 37.6% referent

OR (95% CI) P value
Unadjusted 5.80 (1.94–17.34) 0.002
Adjusted by age 4.76 (1.55–14.60) 0.006
Adjusted by sex 6.48 (2.08–20.17) 0.004
Adjusted by race 7.47 (2.28–24.50) 0.001
Adjusted by closest WBC 6.44 (2.08–19.93) 0.001
Adjusted by ANC 6.20 (2.02–19.03) 0.001
Adjusted by band count 6.91 (2.16–22.14) 0.001
Adjusted by active cancer 4.96 (1.62–15.26) 0.005
Adjusted by SOFA score day 1 4.06 (1.22–13.53) 0.02
Adjusted by APACHE III 4.06 (1.12–14.63) 0.03
Multivariate adjustment* 4.82 (1.15–20.13) 0.03
Adjusted by shock in first 5 days 4.83 (1.56–14.98) 0.006
Adjusted by need for mechanical ventilation first 5 days 4.87 (1.58–14.98) 0.006
*

Multivariate logistic regression of the association of OLFM4 ≥37.6% on mortality adjusted by age, sex, WBC, and APACHE III among 97 patients with sepsis. APACHE III ranges from 0 to 299, with higher scores indicating higher severity of illness. OLFM4, olfactomedin 4; OR, odds ratio; CI, confidence interval; WBC, white blood cell count; ANC, absolute neutrophil count; SOFA, sepsis-related organ failure assessment score; APACHE III, Acute Physiology and Chronic Health Evaluation severity of disease classification system.